Phreesia Lowers FY2027 Sales Guidance from $545.000M-$559.000M to $510.000M-$520.000M

3/30/2026
Impact: -75
Healthcare

Phreesia (NYSE: PHR) has revised its fiscal year 2027 sales guidance, decreasing the forecast from a range of $545 million to $559 million down to $510 million to $520 million.

AI summary, not financial advice

Share: